Entry Detail



General Information

Database ID:exR0091869
RNA Name:hsa-miR-302c-3p
RNA Type:miRNA
Chromosome:chr4
Starnd:-
Coordinate:
Start Site(bp):112648366End Site(bp):112648388
External Links:hsa-miR-302c-3p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
MTMR12
chr5
32226994
32312987
-
TXNIP
chr1
145992435
145996579
-
CLU
chr8
27596917
27614700
-
MBP
chr18
76978827
77133683
-
CCNB1
chr5
69167135
69178245
+
SETD7
chr4
139495941
139606699
-
NUP153
chr6
17615035
17706834
-
SEC16A
chr9
136440096
136483759
-
SLAIN2
chr4
48341529
48426201
+
ZSCAN26
chr6
28267010
28278224
+
CUL1
chr7
148697914
148801110
+
TRA2A
chr7
23504780
23532041
-
TEFM
chr17
30897336
30906238
-
CCNG2
chr4
77157207
77433388
+
CDK6
chr7
92604921
92836594
-
FYCO1
chr3
45917899
45995824
-
PSMD5
chr9
120815496
120842951
-
MTFR2
chr6
136231024
136250335
-
VRK1
chr14
96797382
96931722
+
UGP2
chr2
63840940
63891562
+
KMT5B
chr11
68154863
68213828
-
SEMA3C
chr7
80742538
80922359
-
COX7C
chr5
86617928
86620962
+
SRRT
chr7
100875103
100888664
+
BCL7A
chr12
122019422
122062044
+
PDXK
chr21
43719094
43762307
+
MOB1A
chr2
74152528
74178898
-
MSTO1
chr1
155610188
155614971
+
NPC2
chr14
74476192
74494177
-
CAMK2N1
chr1
20482391
20486210
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000943
chr19
47421744
47440665
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC011503.2
chr19
23927788
23929287
+
AC125257.1
chr17
41848518
41851447
-
AL049840.4
chr14
103694516
103695050
-
ARHGAP27P1-BPTFP1-KPNA2P3
chr17
64749663
64781707
-
FGD5-AS1
chr3
14920347
14948424
-
MIR17HG
chr13
91347820
91354579
+
NEAT1
chr11
65422774
65445540
+
NORAD
chr20
36045618
36051018
-
SNHG16
chr17
76557764
76565348
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.